Easier to quit smoking after a heart attack if there is a hospital-based stop smoking program

NewsGuard 100/100 Score

Researchers in the U.S. say they have found that hospital-based stop smoking programs initiated after a heart attack have more chance of success.

The researchers at Emory University School of Medicine in Atlanta say hospital-based smoking cessation programs, along with referrals to cardiac rehabilitation, appear to increased the rates of quitting smoking following a heart attack.

The researchers carried out a study of 639 patients who smoked at the time of their hospitalisation for heart attack and found that six months later, 297 of the patients, approximately 47% of them, had quit smoking.

The researchers say the odds of quitting were greater among patients who received discharge recommendations for cardiac rehabilitation and those who were treated at a facility offering an inpatient smoking cessation program, whereas individual counseling was not associated with quit rates.

Dr. Susmita Parashar, a cardiologist at Emory says the findings are important because cardiac rehabilitation and hospital-based smoking cessation programs appear to be under-utilized in current clinical practice and should be considered as a structural measure of health care quality for patients who have had a heart attack.

The report appears in the current issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease